Clenpiq and Vertigo aggravated - a phase IV clinical study of FDA data

Summary:

Vertigo aggravated is reported as a side effect among people who take Clenpiq (citric acid; magnesium oxide; sodium picosulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Klonopin, and have Hepatitis chronic active.

The phase IV clinical study analyzes which people have Vertigo aggravated when taking Clenpiq. It is created by eHealthMe based on reports of 591 people who have side effects when taking Clenpiq from the FDA, and is updated regularly.

What is Clenpiq?

Clenpiq has active ingredients of citric acid; magnesium oxide; sodium picosulfate. eHealthMe is studying from 591 Clenpiq users. Check the latest studies of Clenpiq.

What is Vertigo aggravated?

Vertigo aggravated is found to be associated with 2,480 drugs and 713 conditions by eHealthMe. Check the latest studies of Vertigo aggravated.

On Jul, 14, 2026

591 people reported to have side effects when taking Clenpiq.
Among them, 28 people (4.74%) have Vertigo aggravated.

Among these 28 people:

How long have people been on Clenpiq when they have Vertigo aggravated? *

What is the gender of people who have Vertigo aggravated when taking Clenpiq? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Vertigo aggravated when taking Clenpiq? *

What are other drugs people take besides Clenpiq? *

What are other side effects people have besides Vertigo aggravated? *

Nausea (feeling of having an urge to vomit): 14 people, 50.00%
Nausea And Vomiting: 8 people, 28.57%
Headache (pain in head): 6 people, 21.43%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 5 people, 17.86%
Abdominal Pain Upper: 4 people, 14.29%
Loss Of Consciousness: 4 people, 14.29%
Presyncope: 4 people, 14.29%
Weakness: 3 people, 10.71%
Dehydration (dryness resulting from the removal of water): 3 people, 10.71%
Diarrhea: 3 people, 10.71%

What are the existing conditions these people have? *

Seasonal Allergy (allergic condition due to certain season): 1 person, 3.57%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 3.57%
Hypersensitivity: 1 person, 3.57%
Hepatitis Chronic Active: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Clenpiq and have Vertigo aggravated?

- Check whether Vertigo aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clenpiq:

Clenpiq (591 reports)

Vertigo aggravated treatments and more:

Vertigo aggravated (130 reports)

How severe was Vertigo aggravated and when was it recovered:

Vertigo aggravated in Clenpiq

Expand to all the drugs that have ingredients of citric acid; magnesium oxide; sodium picosulfate:

Vertigo aggravated and drugs with ingredients of citric acid; magnesium oxide; sodium picosulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clenpiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vertigo aggravated:

Vertigo aggravated (2,480 drugs)

Browse all the conditions that are associated with Vertigo aggravated:

Vertigo aggravated (713 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on citric acid; magnesium oxide; sodium picosulfate (the active ingredients of Clenpiq) and Clenpiq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.